GHK-Cu vs AHK-Cu hair growth research reveals two copper peptides with distinct specializations: one rebuilds collagen and scalp architecture, the other targets the follicle directly. Here is the comparison.
GHK-Cu vs AHK-Cu hair growth research presents a comparison that is more nuanced than most copper peptide discussions acknowledge. Both are copper-chelating tripeptides. Both have documented effects in dermal and follicular research models. But their molecular structures produce different tissue affinities and different primary mechanisms.
GHK-Cu (glycyl-L-histidyl-L-lysine) primary dermal mechanism involves upregulation of collagen I, collagen III, and elastin synthesis in fibroblasts. This matters because the perifollicular dermis — the connective tissue sheath that physically supports the hair follicle — undergoes progressive degradation in chronic follicle miniaturization.
Copper peptide dermal research published in Biomolecules documented GHK-Cu's broad transcriptional effects. It rebuilds the structural landscape that surrounds the follicle. GHK-Cu also drives angiogenesis through VEGF upregulation, improving the perifollicular microvasculature that delivers nutrients to the dermal papilla.
AHK-Cu (alanyl-histidyl-lysine) differs in its N-terminal amino acid — alanine instead of glycine. This structural difference produces distinct tissue affinity. AHK-Cu's primary documented effect in research is direct enlargement of the hair follicle diameter through expansion of the dermal papilla cell population.
The dermal papilla is the cluster of specialized cells at the base of the follicle that regulates follicle size and the length of the anagen growth phase. Larger papilla correlates with thicker hair fiber production. In cell culture research, AHK-Cu has shown greater dermal papilla cell proliferation stimulation than GHK-Cu, suggesting a more follicle-specific potency.
Both copper peptides modulated androgen pathways in research, but through different mechanisms. GHK-Cu's anti-inflammatory effects reduce the cytokine environment that amplifies DHT-driven miniaturization. AHK-Cu has shown direct evidence of 5-alpha reductase downregulation in cell culture studies, suggesting a more proximal effect on DHT production within the follicle itself.
The combination of GHK-Cu and AHK-Cu in protocols covers the full picture: GHK-Cu rebuilds the scalp microenvironment while AHK-Cu drives direct follicle enlargement.
Join 10,000+ researchers. Get your discount code, early access to new compounds, and protocol insights.
No spam, ever. Unsubscribe anytime.
Check your inbox for your discount code.
Here's a preview:
Valid on all products · Single use
